Vivozon, Inc.
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2008-06-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.vivozon.com
Clinical Trials
11
Trial Phases
3 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (11 trials with phase data)• Click on a phase to view related trials
Phase 3 Efficacy and Safety Study of VVZ-149 Injections for Postoperative Pain Following Bunionectomy
- Conditions
- Pain, Postoperative
- Interventions
- Drug: VVZ-149 InjectionsDrug: Placebo
- First Posted Date
- 2020-06-12
- Last Posted Date
- 2020-07-23
- Lead Sponsor
- Vivozon, Inc.
- Target Recruit Count
- 300
- Registration Number
- NCT04430088
- Locations
- 🇺🇸
Arizona Clinical Trial Site, Phoenix, Arizona, United States
🇺🇸California Clinical Trial Site, Anaheim, California, United States
🇺🇸Texas Clinical Trial Site, San Antonio, Texas, United States
Absorption, Metabolism, Excretion, and Mass Balance Study of [14C]-VVZ-149 in Healthy Adult Male Subjects
- First Posted Date
- 2020-06-04
- Last Posted Date
- 2020-06-04
- Lead Sponsor
- Vivozon, Inc.
- Target Recruit Count
- 6
- Registration Number
- NCT04415645
- Locations
- 🇺🇸
Celerion, Lincoln, Nebraska, United States
Evaluate the Efficacy and Safety of VVZ-149 Injections for the Treatment of Postoperative Pain Following Bunionectomy
- Conditions
- Pain, Postoperative
- Interventions
- Drug: VVZ-149 InjectionsDrug: Placebo
- First Posted Date
- 2019-06-25
- Last Posted Date
- 2020-08-25
- Lead Sponsor
- Vivozon, Inc.
- Target Recruit Count
- 60
- Registration Number
- NCT03997812
- Locations
- 🇺🇸
Anaheim Clinical Trials, Anaheim, California, United States
🇺🇸JBR Clinical Research, Salt Lake City, Utah, United States
Evaluate the Efficacy and Safety of VVZ-149 Injections for the Treatment of Post-Operative Pain Following Abdominoplasty
- Conditions
- Pain, Postoperative
- Interventions
- Drug: PlaceboDrug: VVZ-149 Injections
- First Posted Date
- 2019-06-25
- Last Posted Date
- 2020-08-25
- Lead Sponsor
- Vivozon, Inc.
- Target Recruit Count
- 307
- Registration Number
- NCT03997838
- Locations
- 🇺🇸
Arizona Research Center, Phoenix, Arizona, United States
🇺🇸Anaheim Clinical Trials, Anaheim, California, United States
🇺🇸Midwest Clinical Research Center, Dayton, Ohio, United States
Evaluate the Analgesic Efficacy and Safety of VVZ-149 Injection for Postoperative Pain Following Total Hip Arthroplasty.
- Conditions
- Post-Operative Pain
- Interventions
- Drug: PlaceboDrug: VVZ-149 injections
- First Posted Date
- 2017-11-20
- Last Posted Date
- 2019-03-13
- Lead Sponsor
- Vivozon, Inc.
- Target Recruit Count
- 12
- Registration Number
- NCT03347266
- Locations
- 🇰🇷
Yonsei University Health System, Severance Hospital, Seoul, Korea, Republic of
- Prev
- 1
- 2
- 3
- Next